Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin

被引:16
作者
Chen, LC
Hoeger, C
Rivier, J
Fitzpatrick, VD
Vandlen, RL
Tashjian, AH
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
[4] Genentech Inc, Dept Prot Chem, S San Francisco, CA 94080 USA
关键词
D O I
10.1006/bbrc.1999.0699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The availability of subtype-specific agonists and antagonists for somatostatin (SS) receptors (SSTRs) will be important for elucidation of the function of each receptor isoform in vivo. A SS analog, des-AA(1,2,5)-[D-Trp(8), IAmp(9)]SS (CH275), has been shown previously to bind preferentially to SSTR1. In this report, we identify structural determinants in the ligand and receptor responsible for the selective binding of CH275 to SSTR1 by modifying both the ligand and the receptor, We propose that IAmp(9) in CH275, like Lys(9) in SS, interacts with Asp137 in the middle of the third transmembrane domain of SSTR1 to form an ion pair, while other residues unique to SSTR1 conbribute to binding selectivity of CH275 for SSTR1. Replacement of Asp137 with Asn resulted in loss of binding of radiolabeled SS and decreased potencies of both SS and CH275 to induce a change in the extracellular acidification rate measured by microphysiometry. The structural determinants for specific binding to SSTR1 were mapped in chimeric SSTR1/SSTR2 receptors. One chimera, 2 beta, with the N-terminus to second transmembrane domain (TM2) from SSTR2 and the remainder of the receptor from SSTR1, had low affinity for CH275, Furthermore, when a single residue, Leu107, in TM2 of SSTR1 was replaced with Phe, the corresponding residue in SSTR2, a 20-fold decrease in affinity for CH275 with no significant change in affinity for SS was observed. A reciprocal change from Phe to Leu in the chimeric receptor 2 beta resulted in a 10-fold increase in affinity for CH275. Thus, Leu107 is an important determinant for CH275 binding to SSTR1, To identify the moiety in CH275 which could interact with Leu107, a new analog des-AA(1,2,5)-[D-Trp(8), Amp(9)]SS was prepared. This analog bound to both SSTR1 and SSTR2 with similar affinities; thus, subtype selectivity was lost, Collectively, these data support a binding model for CH275 in which the positively charged IAmp interacts with the negatively charged Asp137 in TM3 of SSTR1 and the isopropyl group of IAmp forms a hydrophobic interaction with Leu107 in TM2. (C) 1999 Academic Press.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 29 条
  • [1] A new action of parathyroid hormone - Receptor-mediated stimulation of extracellular acidification in human osteoblast-like SaOS-2 cells
    Barrett, MG
    Belinsky, GS
    Tashjian, AH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) : 26346 - 26353
  • [2] MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF A BRAIN-SPECIFIC SOMATOSTATIN RECEPTOR
    BRUNO, JF
    XU, Y
    SONG, JF
    BERELOWITZ, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11151 - 11155
  • [3] Binding properties of somatostatin receptor subtypes
    Bruns, C
    Raulf, F
    Hoyer, D
    Schloos, J
    Lubbert, H
    Weckbecker, G
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (08): : 17 - 20
  • [4] Receptor-specific somatostatin analogs: Correlations with biological activity
    Coy, DH
    Taylor, JE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (08): : 21 - 23
  • [5] FITZPATRICK VD, 1994, J BIOL CHEM, V269, P24621
  • [6] FONG TM, 1992, J BIOL CHEM, V267, P25664
  • [7] THE EXTRACELLULAR DOMAIN OF SUBSTANCE-P (NK1) RECEPTOR COMPRISES PART OF THE LIGAND-BINDING SITE
    FONG, TM
    YU, H
    STRADER, CD
    [J]. BIOPHYSICAL JOURNAL, 1992, 62 (01) : 59 - 60
  • [8] MODEL FOR THE STRUCTURE OF BACTERIORHODOPSIN BASED ON HIGH-RESOLUTION ELECTRON CRYOMICROSCOPY
    HENDERSON, R
    BALDWIN, JM
    CESKA, TA
    ZEMLIN, F
    BECKMANN, E
    DOWNING, KH
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 213 (04) : 899 - 929
  • [9] HJORTH SA, 1994, J BIOL CHEM, V269, P30953
  • [10] SOMATOSTATIN ANALOGS - CLINICAL-APPLICATION IN RELATION TO HUMAN SOMATOSTATIN RECEPTOR SUBTYPES
    HOFLAND, LJ
    VISSERWISSELAAR, HA
    LAMBERTS, SWJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (03) : 287 - 297